Innorna Announces FDA Clearance of IND for IN026, Advancing mRNA-based Therapies into Chronic Metabolic Diseases Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/4910635_AE10635_0